Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Scinai Immunotherapeutics Ltd ADR
(NQ:
SCNI
)
3.710
+0.080 (+2.20%)
Streaming Delayed Price
Updated: 3:50 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Scinai Immunotherapeutics Ltd ADR
< Previous
1
2
3
Next >
Syndromic Testing Could Transform Infectious Disease Diagnosis
October 11, 2023
Via
Investor Brand Network
Exposures
COVID-19
Researchers Find Psoriasis Increases Risk of Heart Disease
October 05, 2023
Via
Investor Brand Network
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announces Participation at CPHI Barcelona 2023, Other Upcoming Events
October 04, 2023
Via
Investor Brand Network
Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Secures $1.33 Million from Registered Direct Offering to Boost Commercial Development
October 04, 2023
Via
Investor Brand Network
Why Food Allergy Prevalence Is Growing
September 13, 2023
Via
Investor Brand Network
Scinai Immunotherapeutics to Showcase its end-to-end cGMP Biologics CDMO Services at CPHI Barcelona 2023
October 04, 2023
Targeting biotech companies with drug production process development and optimization, analytical methods development, and GMP production for clinical trials
From
Scinai Immunotherapeutics Ltd.
Via
GlobeNewswire
Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Finalizes Rebrand to Reflect New Strategic Direction, Diversification
October 02, 2023
Via
Investor Brand Network
CDC Avails $262M to New Network Aimed at Responding to Future Disease Outbreaks
September 29, 2023
Via
Investor Brand Network
Inverse Vaccines Show Promise Against Autoimmunity
September 25, 2023
Via
Investor Brand Network
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Closes on $1.33M Registered Direct Offering
September 20, 2023
Via
Investor Brand Network
Scinai Immunotherapeutics Announces Closing of $1.33 Million Registered Direct Offering
September 19, 2023
From
Scinai Immunotherapeutics Ltd.
Via
GlobeNewswire
Study Shows Climate Change Impacts Infectious Disease Risks
September 19, 2023
Via
Investor Brand Network
Topics
Climate Change
Exposures
Climate
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announces $1.33M Registered Direct
September 15, 2023
Via
Investor Brand Network
Scinai Immunotherapeutics Announces $1.33 Million Registered Direct Offering
September 15, 2023
From
Scinai Immunotherapeutics Ltd.
Via
GlobeNewswire
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports on Plaque Psoriasis Treatment Study
September 14, 2023
Via
Investor Brand Network
Exposures
COVID-19
Scinai Immunotherapeutics Innovative Plaque Psoriasis Treatment Shows Encouraging Preclinical Results
September 13, 2023
From
Scinai Immunotherapeutics Ltd.
Via
GlobeNewswire
Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) NanoAbs for Psoriasis Treatment May Offer Significant Advantages Over Apogee
September 12, 2023
Via
Investor Brand Network
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.